[HTML][HTML] Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer

P Schmid, S Adams, HS Rugo… - … England Journal of …, 2018 - Mass Medical Soc
Background Unresectable locally advanced or metastatic triple-negative (hormone-receptor–
negative and human epidermal growth factor receptor 2 [HER2]–negative) breast cancer is …

Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer

P Schmid, S Adams, HS Rugo… - … England Journal of …, 2018 - snucm.elsevierpure.com
BACKGROUND Unresectable locally advanced or metastatic triple-negative (hormone-
receptor-negative and human epidermal growth factor receptor 2 [HER2]-negative) breast …

Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer

P Schmid, S Adams, HS Rugo… - New England Journal …, 2018 - s-space.snu.ac.kr
BACKGROUND Unresectable locally advanced or metastatic triple-negative (hormone-
receptor-negative and human epidermal growth factor receptor 2 [HER2]-negative) breast …

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

P Schmid, S Adams, HS Rugo, A Schneeweiss… - New England Journal …, 2018 - cir.nii.ac.jp
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

P Schmid, S Adams, HS Rugo… - The New England …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Unresectable locally advanced or metastatic triple-negative (hormone-receptor-
negative and human epidermal growth factor receptor 2 [HER2]-negative) breast cancer is …

Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer

P Schmid, S Adams, HS Rugo… - … England Journal of …, 2018 - ohsu.elsevierpure.com
BACKGROUND Unresectable locally advanced or metastatic triple-negative (hormone-
receptor-negative and human epidermal growth factor receptor 2 [HER2]-negative) breast …

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

P Schmid, S Adams, HS Rugo… - The New England …, 2018 - europepmc.org
Background Unresectable locally advanced or metastatic triple-negative (hormone-receptor-
negative and human epidermal growth factor receptor 2 [HER2]-negative) breast cancer is …